Division of Psychology : Research Patients

Research Patients

Schizophrenia Research Study

We are now enrolling participants for a research study to understand the significance of real-world cognitive and functional problems in adults diagnosed with schizophrenia/schizoaffective disorder.
Participants will receive compensation for their time. Sessions will take place at the University of Miami for approximately 4 hours.

To see if you or someone you know qualifies, call Dr. Philip Harvey, University of Miami 305-243-5840.

We are currently enrolling for MOSAIC (The Management of Schizophrenia in Clinical Practice), SCOPE (Social Cognition Psychometric Evaluation),and VRFCAT (Validation Study of the Virtual Reality Functional Capacity Assessment Tool) .

MOSAIC –Is a disease-based registry designed to increase knowledge of the disease course of schizophrenia and the burden of disease among caregivers, clinicians, and for society as a whole. Study staff will follow participants with a DSM-IV TR diagnosis of schizophrenia or schizoaffective disorder treated in usual care settings for up to 5 years. Participants will come to the Clinical Research Building (CRB) every 3 months for the 1st year and every 6 months from years 2-5. At each visit, patients will be evaluated on his/her cognitive function, negative symptoms, and positive symptoms and will be asked about their lifestyle and resource utilization for their disease. Patients will be encouraged to have a caregiver (or informant) and physician to participate in the study.

SCOPE- Social cognitive abilities of individuals with schizophrenia have been strongly linked to functional, real-world social outcomes. As a result, social cognition is increasingly seen as a viable treatment target. In this study, we are evaluating the use of sensitive and accurate social cognitive measures in patients with schizophrenia. Patients will be asked to come to CRB twice over a 2-week period. Patients will be asked to have a high-level informant such as a physician or case worker to participate electronically or via mail.

VRFCAT- This study evaluates the use of a virtual reality program to measure functional capacity in patients with schizophrenia. Currently there is no standard measure of functional capacity of performance-based change. Without a viable measure of changes in functional capacity, approval for new pharmacological treatments may be difficult. In this study, patient will come to the CRB twice over a 2-week period. As with SCOPE, patients will be asked to have an informant.

Please feel free to contact me with any questions or if interested in participating in a study at gvargas3@med.miami.edu or at 305-243-2708.